DL Dr. Lal Pathlabs Stock: price and insider trades · India · SEBI (PIT + SAST)Track the Dr. Lal Pathlabs share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €317bn. The latest transaction was disclosed on 25 August 2026 (Disposal). Among the most active insiders: Amit Aggarwal. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,839 of 28,932 companies
FCF yld 1.4%
Earn yld 1.6%
EV/EBITDA 37.9x
ROE 21%
Gross mgn 81%
Net mgn 18%
Debt/EBITDA 0.2x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 August 2026
All Executives88 Thresholds0 Prospectus0 Other0
Declarations 88 total
● Designated Person · Executives · 25 Aug 2026
500 shares @ ₹1,886.00 Equity Market SaleSEBI:833c68627c5ee4396b5b1571123879b23367795d ▲ Designated Person · Executives · 25 Aug 2026
500 shares @ ₹965.00 Equity ESOPSEBI:f772d5223b541d17e2fc2f13079a9249405a01be Canonical exit: 23 Nov 2026 (T+90) ● Designated Person · Executives · 24 Aug 2026
2,050 shares @ ₹1,885.50 0.0012% mcap 19.5% of flow Equity Market SaleSEBI:4376e9523ad3d0f648588ab3af02364d5adac2d8 ● Other · Executives · 24 Aug 2026
31,300 shares @ ₹1,447.90 0.014% mcap 11.4% of flow Equity ESOPSEBI:f563263a24236b1d16fa28a4815aa812931a929f ▲ Designated Person · Executives · 20 Aug 2026
1,372 shares @ ₹5.00 0.0000% mcap 100.0% of flow Equity ESOPSEBI:908c43951614df9e266e8a1556b4ec8f97742cf1 Canonical exit: 18 Nov 2026 (T+90) ▲ Designated Person · Executives · 18 Aug 2026
7,000 shares @ ₹1,087.50 0.0024% mcap 20.5% of flow Equity ESOPSEBI:6af9f0786f7c400fd601e642bbf7bb81042b28a7 Canonical exit: 16 Nov 2026 (T+90) ● Designated Person · Executives · 18 Aug 2026
3,000 shares @ ₹1,969.30 0.0019% mcap 40.4% of flow Equity Market SaleSEBI:78f4dd1610b332729ea5208f3904d85aeff26ce2 ▲ Designated Person · Executives · 18 Aug 2026
2,050 shares @ ₹1,335.00 0.0009% mcap 17.4% of flow Equity ESOPSEBI:1862d8dba4e9de34d6420f5c700397ba1b0f151c Canonical exit: 16 Nov 2026 (T+90) ● Other · Executives · 18 Aug 2026
15,922 shares @ ₹1,020.40 0.0051% mcap 4.7% of flow Equity ESOPSEBI:18c9b3a022376fe5c9b3b5b68ee78f89625e8989 ▲ Designated Person · Executives · 18 Aug 2026
3,000 shares @ ₹965.00 0.0009% mcap 19.8% of flow Equity ESOPSEBI:c73cc4ced7a7584cbc0830ed7713cf4b7ea02779 Canonical exit: 16 Nov 2026 (T+90) ▲ Designated Person · Executives · 18 Aug 2026
1,372 shares @ ₹5.00 0.0000% mcap 0.2% of flow Equity ESOPSEBI:6d28e0f0a3d6ca3ddb84ad9056be0fdd43a140a8 Canonical exit: 16 Nov 2026 (T+90) ● Designated Person · Executives · 13 Aug 2026
1,000 shares @ ₹1,972.60 0.0006% mcap 11.6% of flow Equity Market SaleSEBI:f2499f41760e7f3238420c76de65776552b91d8f ● Designated Person · Executives · 13 Aug 2026
500 shares @ ₹1,950.00 0.0003% mcap 16.9% of flow Equity Market SaleSEBI:ee920dd794b8328367faf05851dfcb23d19476a9 ● Other · Executives · 13 Aug 2026
8,590 shares @ ₹984.80 0.0026% mcap 2.6% of flow Equity ESOPSEBI:84d06e113f971997ba8635469027406e50de1495 ▲ Designated Person · Executives · 13 Aug 2026
1,000 shares @ ₹1,425.70 0.0004% mcap 8.4% of flow Equity ESOPSEBI:08a780e09322b65d4162f7b72a884146a9ba33f6 Canonical exit: 11 Nov 2026 (T+90) ▲ Designated Person · Executives · 13 Aug 2026
1,700 shares @ ₹1,101.10 0.0006% mcap 14.5% of flow Equity ESOPSEBI:a16d788d0d0736a59465922d0f68f09bc8744a27 Canonical exit: 11 Nov 2026 (T+90) ▲ Designated Person · Executives · 13 Aug 2026
3,000 shares @ ₹965.00 0.0009% mcap 50.2% of flow Equity ESOPSEBI:9ae62ad5f1e3c63e9a9d58eb733631c7cdb9f159 Canonical exit: 11 Nov 2026 (T+90) ● Designated Person · Executives · 13 Aug 2026
1,700 shares @ ₹1,974.50 0.0010% mcap 26.0% of flow Equity Market SaleSEBI:6865efaddf1de45375d60c57a51a77467f24f23f ● KMP · Executives · 11 Aug 2026
1,000 shares @ ₹1,942.00 0.0006% mcap 25.2% of flow Equity Market SaleSEBI:74cf445c451114568b02fe26e0e9b77c0d5c7de9 ● Designated Person · Executives · 10 Aug 2026
1,370 shares @ ₹1,908.90 0.0008% mcap 99.8% of flow Equity Market SaleSEBI:386e27723aaca13a7a4af16e516b93935525531b ● Designated Person · Executives · 10 Aug 2026
6,900 shares @ ₹1,942.80 0.0041% mcap 45.6% of flow Equity Market SaleSEBI:063abf063c51cd768da5184858ea91af94f2a813 ▲ Designated Person · Executives · 7 Aug 2026
6,900 shares @ ₹991.60 0.0021% mcap 43.0% of flow Equity ESOPSEBI:b7edfe9aec16c524b93745bee9732525aba37864 Canonical exit: 5 Nov 2026 (T+90) ▲ Designated Person · Executives · 7 Aug 2026
600 shares @ ₹1,026.30 0.0002% mcap 24.7% of flow Equity ESOPSEBI:2da7b6679fd35427486b48afc8ded504e4271ea6 Canonical exit: 5 Nov 2026 (T+90) ● Designated Person · Executives · 7 Aug 2026
1,250 shares @ ₹1,905.00 0.0007% mcap 17.6% of flow Equity Market SaleSEBI:c9ec14faed1905e291806ad1e2ba63b8a907b68a ● Designated Person · Executives · 7 Aug 2026
500 shares @ ₹1,921.00 0.0003% mcap 12.5% of flow Equity Market SaleSEBI:50cbfd6e3f839705bca3a92324a8879404202946 25 of 88 declarations
Load more (63 remaining) 关于 Dr. Lal Pathlabs Dr. Lal Pathlabs 是一家印度公司,专注于医学诊断服务。它为患者和医疗机构提供广泛的实验室检测服务。